MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 202 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q3 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $24,738 | -19.5% | 3,455 | -2.5% | 0.00% | – |
| Q1 2024 | $30,718 | +18.6% | 3,543 | -10.4% | 0.00% | – |
| Q4 2023 | $25,892 | -20.9% | 3,953 | +20.8% | 0.00% | – |
| Q3 2023 | $32,720 | +188.7% | 3,272 | +258.8% | 0.00% | – |
| Q2 2023 | $11,335 | -86.5% | 912 | -84.8% | 0.00% | – |
| Q1 2023 | $84,185 | +66.3% | 6,009 | +69.9% | 0.00% | – |
| Q4 2022 | $50,614 | -90.7% | 3,537 | -83.5% | 0.00% | -100.0% |
| Q3 2022 | $547,000 | -63.4% | 21,402 | -59.4% | 0.00% | -66.7% |
| Q2 2022 | $1,496,000 | +37300.0% | 52,656 | +52034.7% | 0.00% | – |
| Q1 2022 | $4,000 | -33.3% | 101 | -35.7% | 0.00% | – |
| Q4 2021 | $6,000 | -78.6% | 157 | -72.6% | 0.00% | – |
| Q3 2021 | $28,000 | +16.7% | 574 | -0.7% | 0.00% | – |
| Q2 2021 | $24,000 | +2300.0% | 578 | +1213.6% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 44 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | – | 44 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $269,495,240 | 12.63% |
| 12 West Capital Management LP | 3,361,836 | $41,787,621 | 3.59% |
| Alpine Peaks Capital, LP | 329,424 | $4,094,740 | 2.87% |
| Roubaix Capital, LLC | 235,480 | $2,927,016 | 2.15% |
| Prosight Management, LP | 628,600 | $7,813,498 | 1.17% |
| Cannon Global Investment Management, LLC | 15,800 | $196,394 | 1.02% |
| Curi Wealth Management, LLC | 566,417 | $7,040,564 | 0.95% |
| Mesirow Institutional Investment Management, Inc. | 693,376 | $8,618,664 | 0.89% |
| BRAIDWELL LP | 1,804,700 | $22,432,421 | 0.73% |
| Connacht Asset Management LP | 39,031 | $485,155 | 0.66% |